Human schistosomiasis

被引:2064
|
作者
Colley, Daniel G. [1 ,2 ]
Bustinduy, Amaya L. [3 ]
Secor, Evan [4 ]
King, Charles H. [5 ]
机构
[1] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA
[2] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA
[3] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England
[4] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA
[5] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA
来源
LANCET | 2014年 / 383卷 / 9936期
基金
比尔及梅琳达.盖茨基金会;
关键词
REAL-TIME PCR; PLASMODIUM-FALCIPARUM; HAEMATOBIUM INFECTION; MANSONI INFECTION; IN-VIVO; INTESTINAL SCHISTOSOMIASIS; UROGENITAL SCHISTOSOMIASIS; POLYPARASITIC INFECTIONS; GENITAL SCHISTOSOMIASIS; COGNITIVE IMPAIRMENT;
D O I
10.1016/S0140-6736(13)61949-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human schistosomiasis-or bilharzia-is a parasitic disease caused by trematode flukes of the genus Schistosoma. By conservative estimates, at least 230 million people worldwide are infected with Schistosoma spp. Adult schistosome worms colonise human blood vessels for years, successfully evading the immune system while excreting hundreds to thousands of eggs daily, which must either leave the body in excreta or become trapped in nearby tissues. Trapped eggs induce a distinct immune-mediated granulomatous response that causes local and systemic pathological effects ranging from anaemia, growth stunting, impaired cognition, and decreased physical fitness, to organ-specific effects such as severe hepatosplenism, periportal fibrosis with portal hypertension, and urogenital inflammation and scarring. At present, preventive public health measures in endemic regions consist of treatment once every 1 or 2 years with the isoquinolinone drug, praziquantel, to suppress morbidity. In some locations, elimination of transmission is now the goal; however, more sensitive diagnostics are needed in both the field and clinics, and integrated environmental and health-care management will be needed to ensure elimination.
引用
收藏
页码:2253 / 2264
页数:12
相关论文
共 50 条
  • [1] Human schistosomiasis
    Gryseels, Bruno
    Polman, Katja
    Clerinx, Jan
    Kestens, Luc
    LANCET, 2006, 368 (9541): : 1106 - 1118
  • [2] Human schistosomiasis
    Buonfrate, Dora
    Ferrari, Teresa Cristina A.
    Adegnika, Ayola Akim
    Stothard, J. Russell
    Gobbi, Federico G.
    LANCET, 2025, 405 (10479): : 658 - 670
  • [3] HUMAN SCHISTOSOMIASIS IN INDIA
    GADGIL, RK
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1963, 51 (02) : 244 - &
  • [4] Immunology of human schistosomiasis
    Colley, D. G.
    Secor, W. E.
    PARASITE IMMUNOLOGY, 2014, 36 (08) : 347 - 357
  • [5] IMMUNITY IN HUMAN SCHISTOSOMIASIS
    BUTTERWORTH, AE
    HAGAN, P
    PARASITOLOGY TODAY, 1987, 3 (01): : 11 - 16
  • [6] HUMAN SCHISTOSOMIASIS IN INDIA
    SOUTHGATE, VR
    AGRAWAL, MC
    PARASITOLOGY TODAY, 1990, 6 (05): : 166 - 168
  • [7] IMMUNITY IN HUMAN SCHISTOSOMIASIS
    BUTTERWORTH, AE
    ACTA TROPICA, 1987, 44 (02) : 31 - 40
  • [8] HUMAN SCHISTOSOMIASIS IN CAMEROON .1. DISTRIBUTION OF SCHISTOSOMIASIS
    RATARD, RC
    KOUEMENI, LE
    BESSALA, MME
    NDAMKOU, CN
    GREER, GJ
    SPILSBURY, J
    CLINE, BL
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 42 (06): : 561 - 572
  • [9] Immunopathogenesis of human schistosomiasis
    Burke, M. L.
    Jones, M. K.
    Gobert, G. N.
    Li, Y. S.
    Ellis, M. K.
    Mcmanus, D. P.
    PARASITE IMMUNOLOGY, 2009, 31 (04) : 163 - 176
  • [10] Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies
    Abdul-Ghani, Rashad A.
    Hassan, Azza A.
    PARASITOLOGY RESEARCH, 2010, 107 (01) : 1 - 8